Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood.

Neutropenia treatment industry is projected to witness a CAGR of 4.1% during the period 2024-2032. This growth can be ...

Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood. Neutrophils ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

作者：蓝鲸晓虎免疫功能低下的患者发生细菌、病毒和真菌感染等感染性并发症的风险较高，为患者带来严重痛苦，延长治疗时间。感染是血液系统患儿死亡的重要原因，发生感染时常需中止化疗。本文以近年来发布的指南为依据，总结接受化疗或接受造血干细胞移植（HSCT）患 ...

Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Late-onset neutropenia (LON) is emerging as a common adverse effect to rituximab therapy owing to widespread use of this drug in the treatment of B-cell lymphomas and autoimmune diseases.

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Neutropenia in individuals with a congenital defect or patients with cancer who are undergoing chemotherapy is generally treated with granulocyte colony-stimulating factor (G-CSF) to restore ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

Explore the potential of Celldex's Barzolvolimab in Phase 3 for CSU, with strong efficacy but safety concerns, promising ...

Overall, neurologic toxicities occurred in 64% (12% grade ≥3). Other common non-laboratory adverse events, occurring in 20% ...